Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
ChemMedChem(1)
Current Pharmaceutical Design(1)
Drug Discovery Today: Therapeutic Strategies(1)
Expert Opinion on Drug Discovery(1)
Expert Opinion on Investigational Drugs(1)
Área temáticas
Farmacología y terapéutica(7)
Enfermedades(4)
Fisiología humana(2)
Ginecología, obstetricia, pediatría, geriatría(2)
Fisiología y materias afines(1)
Origen
scopus(8)
An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders
ReviewAbstract: Importance of the field: The increase in life expectancy in developed countries has given rise to sePalabras claves:Alzheimer's disease, apoptosis, Neuroprotective drugs, Parkinson's DiseaseAutores:Antoni Camins, Folch J., Junyent F., Pallás M., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopusAntiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseases
ReviewAbstract: The purpose of this review is to discuss potential pathways involved in the pathogenesis of neurodegPalabras claves:Alzheimer's disease, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Neuroprotective drugs. apoptosis, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Sureda F.X., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusAging biology: A new frontier for drug discovery
ReviewAbstract: Introduction: The prevalence of age-related pathologies, such as cardiovascular disease, neurodegenePalabras claves:Autores:Antoni Camins, Auladell C., Folch J., Junyent F., Pallás M., Verdaguer E., Zárate C.B.Fuentes:scopusAging control with resveratrol
ReviewAbstract: The prevalence of age-related pathologies such as neurodegenerative disease and diabetes type II hasPalabras claves:Autores:Antoni Camins, Junyent F., Pallás M., Verdaguer E., Zárate C.B.Fuentes:scopusNovel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates
ArticleAbstract: A new family of dual binding site acetylcholinesterase (AChE) inhibitors has been designed, synthesiPalabras claves:Acetylcholinesterase, drug design, Inhibitors, β-amyloid peptides, β-secretaseAutores:Andrisano V., Antoni Camins, Arce M.P., Badia A., Bartolini M., Bidon-Chanal A., Camps P., Clos M.V., Galdeano C., Gómez T., Junyent F., Luque F.J., Mancini F., Muñoz-Torrero D., Pallás M., Ramírez L., Ratia M., Rodríguez-Franco M.I., Verdaguer E., Viayna E.Fuentes:scopusResveratrol: A therapeutic approach to neurodegenerative diseases and aging
ArticleAbstract: Resveratrol (3,5,4′-trihydroxystilbene) is a polyphenol present in black grapes and its derivatives.Palabras claves:cell cycle, Oxidative Stress, Sirtuin 1Autores:Antoni Camins, Canudas A.M., Jiménez A., Junyent F., Pallás M., Verdaguer E.Fuentes:scopusResveratrol: An antiaging drug with potential therapeutic applications in treating diseases
ReviewAbstract: The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the dPalabras claves:Alzheimer’s disease, Parkinson’s Disease, Resveratrol, Sirt1Autores:Antoni Camins, Junyent F., Ortuo-Sahagún D., Pallás M., Rojas-Mayorquín A.E., Verdaguer E., Zárate C.B.Fuentes:scopusPrevention of epilepsy by taurine treatments in mice experimental model
ArticleAbstract: An experimental model based on kainic acid (KA) injections replicates many phenomenological featuresPalabras claves:Kainic acid, Neurodegeneration, neuroprotectionAutores:Antoni Camins, Auladell C., Duque D., Junyent F., Pallás M., Romero R., Utrera J.Fuentes:scopus